The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Kura Oncology Inc shares valued at $231,934 were purchased by FRANCIS J BURROWS on Dec 18 ’25. At $9.78 per share, FRANCIS J BURROWS acquired 23,726 shares.
Also, Hasnain Faheem sold 10,000 shares, netting a total of over 109,764 in proceeds. Following the sale of shares at $10.98 each, the insider now holds 23,983 shares.
Before that, FAHEEM HASNAIN had added 10,000 shares to its account. In a trade valued at $116,400, the Director bought Kura Oncology Inc shares for $11.64 each.
As published in their initiating research note from Guggenheim on September 04, 2025, Kura Oncology Inc [KURA] has been a Neutral. Analysts at BTIG Research downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early February. As of October 24, 2024, UBS has initiated its “Buy” rating for KURA. Earlier on October 14, 2024, Stifel downgraded its rating. Their new recommendation was “a Hold” for KURA stock which previously was a “a Buy”.
Analyzing KURA Stock Performance
On last trading session, Kura Oncology Inc [NASDAQ: KURA] plunged -3.24% to $9.85. The stock’s lowest price that day was $9.68, but it reached a high of $10.28 in the same session. During the last five days, there has been a drop of approximately -5.83%. Over the course of the year, Kura Oncology Inc shares have dropped approximately -1.25%. Shares of the company reached a 52-week high of $12.49 on 11/14/25 and a 52-week low of $5.41 on 04/07/25.
Support And Resistance Levels for Kura Oncology Inc (KURA)
According to the 24-hour chart, there is a support level at 9.59, which, if violated, would cause prices to drop to 9.34. In the upper region, resistance lies at 10.19. The next price resistance is at 10.54. RSI (Relative Strength Index) is 38.88 on the 14-day chart, showing neutral technical sentiment.
Is Kura Oncology Inc subject to short interest?
Stocks of Kura Oncology Inc saw a sharp steep in short interest on 2025-11-28 dropping by -0.69 million shares to 7.99 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 8.68 million shares. A decline of -8.58% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.83 of the overall float, the days-to-cover ratio (short ratio) decline to 3.83.
Which companies own the most shares of Kura Oncology Inc (KURA)?
In terms of Kura Oncology Inc share price expectations, FactSet research, analysts set an average price target of 38 in the next 12 months, up nearly 273.28% from the previous closing price of $10.18. Analysts anticipate Kura Oncology Inc stock to reach 40 by 2025, with the lowest price target being 28. In spite of this, 3 analysts ranked Kura Oncology Inc stock as Buy at the end of 2025. On December 22, 2023, Mizuho assigned a price target of “a Buy” to the stock and initiated coverage with a $26.
